Interaction between Metal in Metallo Enzyme and Small Biological Molecules

In this work, the existence of interaction between metal in metallo enzyme and small biological molecules such as amino acid in aqueous solution is confirmed for the first time by the experimental data of ESR, NMR,UV-VIS and enzyme activity. This kind of interaction can affect the enzyme catalytic activity.

Nanotube-Based Chemical and Biomolecular Sensors

We present a brief review about recent results regarding carbon nanotube （CNT）-based chemical and biomolecular sensors. For the fabrication of CNT-based sensors, devices containing CNT channels between two metal electrodes are first fabricated usually via chemical vapor deposition （CVD） process or ＂surface programmed assembly＂ method. Then, the CNT surfaces are often functionalized to enhance the selectivity of the sensors. Using this process, highly-sensitive CNT-based sensors can be fabricated for the selective detection of various chemical and biological molecules such as hydrogen, ammonia, carbon monoxide, chlorine gas, DNA, glucose, alcohol, and proteins.

Synthesis and Crystal Structure of 5-Methoxy- butyrolacto[3,4-b]-1-N-cyclohexylaziridine

The title compound, 5-methoxy-butyrolacto[3,4-b]-1-N-cyclohexylaziridine 1, has been synthesized via tandem Micheal addition and intramolecular nucleophilic substitution reactions of 5-methoxy-3-bromo-2（5H）-furanones 4 with primary amines 5, and structurally determined by single-crystal X-ray diffraction. Crystal data： C11H17NO3, Mr = 211.26, monoclinic system, space group P21/c, a = 17.800（3）, b = 5.3864（10）, c = 12.2571（10）A°, β = 90.449（3）°, V = 1175.1（3） A°^3, Z= 4, De= 1.194 g/cm^3, λ（MoKα） = 0.071073 nm, μ = 0.087 mm^-1 and F（000） = 456. The structure was refined to R = 0.0505 and wR = 0.1208 for 2579 observed reflections （I 〉 2σ（I））. The crystallographic results of molecule 1 show that the functionalized aziridine ring is fused with a lactone ring to form the component with [3.1.0] bicyclic skeleton.

Synthesis and Crystal Structure of 2,3-Dihydroxymethyl-N-cyclohexylaziridine

The title compound, 2（S）,3（R）-dihydroxymethyl-N-cyclohexylaziridine 1, has been synthesized via tandem Micheal addition and internal nucleophilic substitution reactions of 5-methoxy-3-bromo-2（5H）-furanones 2 with cyclohexylamine 3 and subsequent reduction of intermediate 5. Its crystal structure was determined by single-crystal X-ray diffraction. Crystal data：C10H19NO2, Mr = 185.26, monoclinic system, space group P21/n, a = 8.0620（16）, b = 7.2013（14）, c= 18.555（4） A°, β= 102.30（3）°, V= 1052.5（4）A°^3, Z= 4, De= 1.169 g/cm^3, λ（MoKα） = 0.071073 nm,μ = 0.080 mm^- 1 and F（000） = 408. The structure was refined to R = 0.0439 and wR = 0.1178 for 1839 observed reflections （I 〉 2σ（I））. The crystallographic structure of 1 shows that the functionalized aziridine ring links two hyroxymethyl groups.

A Valuable Synthetic Route to the Enantiopure Functionalized N-Substituted Aziridines

Chiral butyrolacto[3,4-b]-2(S)-6(R)-1-N-akylaziridines 7 were synthesized in enantiopure form utilizing racemic 5-methoxy-3-bromo-2(5H)-furanone (5) and available amines (6) as key precursors. After highly effective reduction of 7, the functionalized 2(S),3(R)-dihyroxymethyl-N-alkylaziridines (8) were obtained in good yields with ≥98% ee. This is a simple and pratical method for the preparation of enantiopure aziridines which are important interme-diates in the synthesis of biologic active molecules.

Constructive strategies for drug delivery systems in antivirus disease therapy by biosafety materials

Due to the coronavirus disease 2019(COVID‐19)pandemic,the development of antiviral drugs has attracted increasing attention.Clinical antiviral drugs show weak solubility,low bioavailability,adverse side effects,or only limited targets.With the advancement of nanotechnology and material science,biosafety nanomaterials have been constructed for drug delivery systems of antiviral disease therapy,such as liposomes,polymers,gold nanoparticles,and graphene.These nanodrug systems can either deliver synthesized antiviral drugs siRNA/miRNA and small molecular compounds,deliver bioactive large molecular drug proteins and mRNA,or show antiviral activity by themselves.Nanodelivery systems could effectively enhance the efficiency of antiviral drugs by increasing drug loading and host cell uptake with a small size and high specific surface area.This review focused on the biosafety nanomaterials used for antiviral therapy and discussed the options for the design of antiviral drugs in the future.